arrow
T

Tanja Nicole Hartmann

University of Freiburg
H指数:36
被引数:4,050

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies

STAT5-activating癌基因诱导的制瘤素M促进血液系统恶性肿瘤的疾病进展

2025-12-110
OAAI
Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia
2024-12-230
PRE
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma

感染或疫苗接种后SARS-CoV-2-Specific CD8 T细胞受损,但多发性骨髓瘤患者的混合T细胞免疫功能强大

2024-11-010
OAAI
Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis
2024-09-021
OAAI
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands
LEUKEMIA
IF13.4
2024-08-141
OAAI
A 3D bioreactor model to study osteocyte differentiation and mechanobiology under perfusion and compressive mechanical loading
2024-08-010
OAAI
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
2024-05-310
OAAI
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
2022-12-2117
OAAI
Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation
2021-12-106
OA
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia
2021-11-225
PREAI
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
2020-07-0227
OAAI
TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
LEUKEMIA
IF13.4
2020-02-213
OAAI